|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/20 | |
| A61K 47/40 | |||
| A61K 47/34 | |||
| A61K 47/26 | |||
| A61K 47/12 | |||
| A61K 31/4152 | |||
| A61K 31/045 | |||
| A61P 9/10 | |||
| A61K 9/00 |
| (11) | Patento numeris | 3505161 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17845291.8 |
| Europos patento paraiškos padavimo data | 2017-08-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-07-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-05-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2017/098620 |
| Data | 2017-08-23 |
| (87) | Numeris | WO 2018/040989 |
| Data | 2018-03-08 |
| (30) | Numeris | Data | Šalis |
| 201610761890 | 2016-08-29 | CN |
| (72) |
WANG, Yijun, CN
|
| (73) |
Neurodawn Pharmaceutical Co., Ltd.,
L3244, 3rd Floor, Chuangye Building No. 1009 Tianyuan East Road Jiangning District, Nanjing, Jiangsu 211199,
CN
Simcere Pharmaceutical Co. Ltd., No. 99, Huakang Road, Jiangbei New District, Nanjing Jiangsu 210032, CN |
| (54) | SUBLINGUAL PHARMACEUTICAL COMPOSITION OF EDARAVONE AND (+)-2-BORNEOL |
| SUBLINGUAL PHARMACEUTICAL COMPOSITION OF EDARAVONE AND (+)-2-BORNEOL |